Affomix to create antibodies against proprietary targets chosen by Kalgene Affomix Corporation for sale.

Affomix to create antibodies against proprietary targets chosen by Kalgene Affomix Corporation, a pioneer in the advancement of automated, high-throughput monoclonal antibody selection technology, today that Kalgene announced Pharmaceuticals Inc for sale . Kalgene Pharmaceuticals Inc. Financial conditions of the ongoing service agreement were not disclosed, nor were the monetary milestones related to diagnostic and therapeutic applications. T. Nathan Yoganathan, President and CEO of Kalgene Pharmaceuticals Inc.

Medical risk assessment provides employees with information regarding their personal health needs and motivates them to make lasting positive changes. The online assessment can also help them understand feasible health risks, and provides an action strategy and info that encourages healthy behaviours.. Aetna introduces new IHP for employees to look at healthy behaviours Aetna , a respected global diversified healthcare benefits organization, today announced the launch of a new suite of International Healthcare Plans for companies with globally mobile workers. Aetna offers revamped its primary health advantages plans to respond to client and member needs and included its industry-leading health risk evaluation free of charge within its package of wellness tools and resources to encourage employees to look at healthy behaviours.